200 related articles for article (PubMed ID: 28810525)
1. In vitro anticancer activities of osthole against renal cell carcinoma cells.
Liu L; Mao J; Wang Q; Zhang Z; Wu G; Tang Q; Zhao B; Li L; Li Q
Biomed Pharmacother; 2017 Oct; 94():1020-1027. PubMed ID: 28810525
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
3. Osthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways.
Ding D; Wei S; Song Y; Li L; Du G; Zhan H; Cao Y
Cell Physiol Biochem; 2013; 32(6):1751-60. PubMed ID: 24356539
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of osthole on ovarian cancer cells in vitro.
Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W
J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
6. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells.
Lin ZK; Liu J; Jiang GQ; Tan G; Gong P; Luo HF; Li HM; Du J; Ning Z; Xin Y; Wang ZY
Oncol Rep; 2017 Mar; 37(3):1611-1618. PubMed ID: 28184928
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells.
Zhao Y; Tang H; Zeng X; Ye D; Liu J
Biomed Pharmacother; 2018 Feb; 98():36-44. PubMed ID: 29241073
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
10. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH
Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731
[TBL] [Abstract][Full Text] [Related]
11. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract][Full Text] [Related]
13. Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM/NF‑κB signaling.
Che Y; Li J; Li Z; Li J; Wang S; Yan Y; Zou K; Zou L
Oncol Rep; 2018 Aug; 40(2):737-747. PubMed ID: 29989651
[TBL] [Abstract][Full Text] [Related]
14. Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Chao X; Zhou X; Zheng G; Dong C; Zhang W; Song X; Jin T
Pharm Biol; 2014 May; 52(5):544-50. PubMed ID: 24236568
[TBL] [Abstract][Full Text] [Related]
15. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L
PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
[TBL] [Abstract][Full Text] [Related]
18. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro.
Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M
Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470
[TBL] [Abstract][Full Text] [Related]
19. Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro.
Xu XM; Zhang Y; Qu D; Feng XW; Chen Y; Zhao L
Mol Med Rep; 2012 Nov; 6(5):1018-22. PubMed ID: 22923177
[TBL] [Abstract][Full Text] [Related]
20. Effects of osthole on migration and invasion in breast cancer cells.
Yang D; Gu T; Wang T; Tang Q; Ma C
Biosci Biotechnol Biochem; 2010; 74(7):1430-4. PubMed ID: 20622464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
